CRWV entered the week riding a wave of analyst upgrades — then gave it all back.
The stock posted its Q1 results on May 7, reporting what management described as the company's strongest bookings in its history. Analysts responded by lifting price targets across the board. By May 11, at least ten firms had raised their numbers, with targets running from JPMorgan's cautious $105 all the way to Cantor Fitzgerald's $167. Yet despite that collective re-rating, CRWV fell 6.1% on Tuesday and finished the week down nearly 16%, retracing from the post-earnings bounce to close at $107.75.
The split between the Street's direction of travel and the stock's price action is the central tension this week. Almost every firm that updated raised its target, which is unusual unanimity. But the firms themselves are divided on conviction. Bulls — Cantor Fitzgerald, Wells Fargo, Jefferies, and Citigroup, all maintaining Overweight or Buy ratings with targets of $155–$167 — point to a growing backlog, new contracts with Meta and Anthropic, and what they see as durable pricing power in AI infrastructure. The bears, or more precisely the cautious, include JPMorgan and Barclays, both holding sidelined ratings (Neutral and Equal-Weight) even after nudging their targets to $105 and $120 respectively. JPMorgan's $105 target is now sitting below the current price of $107.75 — a notable signal that the stock has essentially traded through the range where at least one bellwether firm sees fair value. The mean target across the group is $141.32, implying roughly 31% upside from where the stock closed. EV/EBITDA has compressed to 8.1x over the past month, tightening from around 9.4x thirty days ago.
Short sellers have been quietly adding positions into the earnings event and its aftermath. Short interest climbed 5.8% over the week to 15.5% of free float, a meaningful level for a stock that only went public earlier this year. That said, the borrow market does not look particularly stressed. Cost to borrow is running at just 0.41% annualised — cheap by any measure — and availability has eased materially in recent weeks. Utilisation of the lending pool has fallen from a peak of around 28% in early April to just over 10%, meaning there is ample room for new short positions to be established without squeezing existing ones. Options traders have shifted modestly more defensive, with the put/call ratio at 0.88, slightly above its 20-day average of 0.85, but the z-score of 1.26 is nowhere near the levels that would signal a crowded hedge. The ORTEX short score has drifted lower through the week — from 54.1 on May 7 to 52.3 by May 12 — reinforcing the picture of a short position that is growing in size but not in urgency.
The ownership picture adds a layer of complexity. Magnetar Capital, the largest institutional holder with a 10.8% stake, sold a cluster of small tranches on May 7 — the day of the earnings release — at prices between $130 and $133. Those sales came as the stock was trading well above where it ended the week. Co-founder Brian Venturo has also reduced his position, shedding roughly 7 million shares in recent filings. CEO Michael Intrator trimmed by 1.9 million shares. None of these are dramatic single trades, but the aggregate insider direction is net selling among the founders and lead investor at prices meaningfully above where the stock subsequently settled. On a 90-day basis, net insider activity shows a small positive balance of roughly 594,000 shares, largely reflecting option awards and conversions rather than open-market buying.
The next scheduled earnings event is June 8. After a 17.3% single-day drop following the May 7 report, the market has a clear data point on how much the stock can move on results day. Analysts describe the revenue profile as "lumpy and volatile" by design — the business is heavily contract-driven, with large single deals moving reported numbers meaningfully quarter to quarter. The June event will therefore be less about whether AI infrastructure demand exists and more about whether the bookings momentum management cited can convert into the kind of clean revenue progression that sideline-rated firms like JPMorgan and Barclays need to see before moving off the fence.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
